MeSH D002051 - burkitt lymphoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cyclophosphamide | Neosar | 1993-04-29 | |||
| Dr Reddys Laboratories | Cyclophosphamide | Cyclophosphamide | 2036-02-15 | 2020-07-30 | ||
| Cipla | Cyclophosphamide | Cyclophosphamide | 2019-01-18 | |||
| Alembic Pharmaceuticals | Cyclophosphamide | Cyclophosphamide | 2022-11-10 | |||
| Amneal Pharmaceuticals | Cyclophosphamide | Cyclophosphamide | 2018-05-25 | |||
| ANI Pharmaceuticals | Cyclophosphamide | Cyclophosphamide | 2018-03-19 | |||
| Hikma Pharmaceuticals | Cyclophosphamide | Cyclophosphamide | 2013-09-16 | |||
| Roxane Laboratories | Cyclophosphamide | Cyclophosphamide | 1999-08-17 | |||
| Eugia Pharma Specialties | Cyclophosphamide | Cyclophosphamide | 2035-06-26 | 2021-08-25 | ||
| Baxter | Cyclophosphamide | Cyclophosphamide | 2008-05-21 | |||
| Cyclophosphamide | Cytoxan | 1982-01-01 | ||||
| Cyclophosphamide | Cytoxan (lyophilized) | 1982-01-01 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
72%72/100
Phase 2
20%20/99
Phase 3
44%4/9
Approved: 1Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use